Clinical Trials Directory

Trials / Unknown

UnknownNCT00899327

Biomarkers in Patients at Risk of Developing Myelodysplastic Syndrome or Other Disorders and in Healthy Participants

Molecular and Functional Characterisation of Bone Marrow Function in Normal Subjects, Myelodysplastic Syndromes (MDS) and Secondary Disorders of Heamatopoiesis

Status
Unknown
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
Oxford University Hospitals NHS Trust · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

RATIONALE: Studying samples of blood and bone marrow in the laboratory from patients at risk of developing myelodysplastic syndrome may help doctors learn more about changes that occur in DNA and identify biomarkers related to disorders of the blood and bone marrow. PURPOSE: This research study is looking at biomarkers in patients at risk of developing myelodysplastic syndrome or other disorders and in healthy participants.

Detailed description

OBJECTIVES: Primary * To identify novel biomarkers of disease that would help in the initial diagnosis of myelodysplastic syndromes (MDS). Secondary * To understand the genesis of anemia in cancers. * To identify novel biomarkers of disease that predict progression of MDS to acute myeloid leukemia. OUTLINE: Blood and bone marrow samples are collected. Hemopoietic stem cells (HSC) and progenitor cells are isolated from samples for analysis. Some of these HSC and progenitor cells are used for functional assays. From the rest of the cells, DNA, RNA, and protein is extracted for molecular analyses, including gene mutation analysis, gene methylation assays, chromatin immunoprecipitation, microarray, and real-time polymerase chain reaction.

Conditions

Interventions

TypeNameDescription
GENETICDNA methylation analysis
GENETICRNA analysis
GENETICcytogenetic analysis
GENETICgene expression analysis
GENETICmutation analysis
GENETICpolymerase chain reaction
GENETICprotein expression analysis
OTHERlaboratory biomarker analysis

Timeline

Start date
2007-01-01
Primary completion
2011-12-01
First posted
2009-05-12
Last updated
2009-07-08

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT00899327. Inclusion in this directory is not an endorsement.